Investegate announcements from LumiraDx Inc, LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK
Progress on Near-Term Growth Opportunities and Cost SavingsLONDON, Nov. 09, 2022 LumiraDx Limited , a next-generation point of care diagnostics company, today announced operational and. | November 9, 2022
Progress on Near-Term Growth Opportunities and Cost SavingsLONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced
Strong Pipeline Progress and Commercialization Priorities for Newly Authorized ProductsLONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics